NCT01088880View on ClinicalTrials.gov

Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Familial Mediterranean Fever
Interventions
DRUG

Canakinumab

Trial Locations (1)

Unknown

Istanbul Medical Faculty, Dept of Rheumatology, Capa, Istanbul

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY